Market Introduction
Cell Line Development is the procedure by which cells are developed under controlled conditions, for the most part outside their common habitat. The cell line is established cell culture, which gets increased numerous times when supplied with the growth medium and space for growth. Cell line development have variety of application in healthcare and life science industry such as drug screening, drug development, production of bio production. Different cell lines can be made from different cells. The cell line plays a vital role in the study of cytology. The cell line enables stepwise alterations in the structure, physiology, and genetic makeup of cells under a customized environment.
Market Overview and Dynamics
The Middle East and Africa cell line development market is expected to reach US$ 626.07million in 2027 from US$ 247.84million in 2019. The market is estimated to grow with a CAGR of 12.4% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as the increasing focus on the research and development activities regarding cell line development market and a higher prevalence of cancer cases. However, the market growth is likely to be hindered owing to the several issues related to the cell line development market.
Key Market Segments
Based on type, the cell line development market is segmented into primary cell line, hybridomas, continuous cell lines, and recombinant cell line. Based on product, the cell line development market is segmented into equipment, and media & reagent. Based on application, the cell line development market, is segmented into drug discovery, bioproduction, and tissue engineering.
Major Sources and Companies Listed
Some of the major primary and secondary sources for cell line development market included in the report are The Cancer Association of South Africa (CANSA), Dubai Health Authority (DHA), and others.
Reasons to buy the report
- To understand the Middle East and Africa cell line development market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for cell line development market
- Efficiently plan M&A and partnership deals in Middle East and Africa cell line development market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form cell line development market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in Middle East and Africa region
MIDDLE EAST AND AFRICA CELL LINE DEVELOPMENT MARKET SEGMENTATION
By Type
· Primary Cell Line
· Hybridomas
· Continuous Cell Lines
· Recombinant Cell Line
· Equipment
· Media & Reagent
· Drug Discovery
· Bioproduction
By Country
· Middle East and Africa
· UAE
· South Africa
· Rest of Middle East and Africa
Company Profiles
· General Electric
· Lonza
Middle East and Africa Cell Line Development Market Strategic Insights
Middle East and Africa Cell Line DevelopmentMarket Report Highlights
| Report Attribute | Details |
| Market size in 2019 | US$ 247.84 Million |
| Market Size by 2027 | US$ 626.07 Million |
| CAGR (2020 - 2027) | 12.4% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Type
|
|
Regions and Countries Covered
|
|
| Middle East and Africa | South Africa, Saudi Arabia, UAE, Rest of Middle East and Africa |
| Market leaders and key company profiles |
|
Middle East and Africa Cell Line Development Market Country and Regional Insights
